Showing results (881-890 of 5,112) with videos related to

Sort By:
Pageof 512
Intensive Care Medicine Experimental|February 9, 2024
Mesenchymal stem cells-based therapies for severe ARDS with ECMO: a reviewJing-Ke Cao, Xiao-Yang Hong, Zhi-Chun Feng, et al.
International Journal of Biological Macromolecules|May 10, 2024
Synergism of jet milling and deep eutectic solvent pretreatment on grapevine lignin fractionation and enhancing enzymatic hydrolysisYuan Zhu, Tian-Xiao Yang, Hang Li, et al.
Heliyon|October 9, 2023
Circular RNA circWHSC1 facilitates colorectal cancer cell proliferation by targeting miR-130a-5p/zeb1 signaling in vitro and in vivoLei Shi, Yuanshun Zhao, Xu Liu, et al.
Journal of Clinical Lipidology|September 18, 2023
Remnant cholesterol predicts cardiovascular mortality beyond low-density lipoprotein cholesterol in patients with peritoneal dialysisJing Guo, Yuan Peng, Ruihua Liu, et al.
Translational Andrology and Urology|March 11, 2026
Development and validation of a gemcitabine sensitivity-related long noncoding RNA signature for predicting the prognosis and subtypes of bladder cancerJia Liu, Xingxing Tang, Yushuang Cui, et al.
Iscience|March 9, 2026
Quantitative assessment of water-related ecological security patterns based on ecosystem service flows: A case study of Jilin Province, ChinaQing Ru, Xiao Yang, Yang Liu, et al.
The European Journal of Neuroscience|February 20, 2026
Active Task Engagement Enhances Auditory Brain-Behaviour Prediction From Single-Trial EEG Compared With Passive ListeningZhaonan Ma, Xiaoyu Wang, Xiao Yang, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|March 17, 2010
[Preparation of polyclonal antibody against human Fkbp19]Kai-ji Fan, Yan Zhang, Nai-fa Liu, et al.
Pediatric Health, Medicine and Therapeutics|March 26, 2026
A Case of Childhood Lupus Anticoagulant-Hypoprothrombinemia Syndrome with Diagnostic and Therapeutic InsightBi Zhou, Wanyan Jiao, Ying Li, et al.
Translational Lung Cancer Research|June 15, 2026
Endostar combined with PD-1 blockade, radiotherapy, GM-CSF, and IL-2 (PRaG 2.0E) for refractory non-small cell lung cancer: a single-arm, phase II clinical trial (PRaG2.0E Study Protocol)Shuaiyi Huang, Xiao Yang, Xiangrong Zhao, et al.
Pageof 512